| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |